(Press-News.org) Hercules, CA -- May 29, 2015 -- Researchers at Harvard Medical School and the Digital Biology Center at Bio-Rad Laboratories, Inc. have developed a rapid, scalable, and cost-effective method for chromosomal phasing that provides researchers with a new method to determine if genetic variants are linked on the same chromosome. Using Bio-Rad's Droplet Digital PCR (ddPCRTM) technology, the Drop-Phase method can rapidly determine the chromosomal phase of allelic markers hundreds of kilobases apart. This ability may provide new insights into the cause, penetrance, and severity of diseases. The collaborators recently published their findings in the journal PLOS ONE in a research article titled "A rapid molecular approach for chromosomal phasing."
The "phase" (or linked arrangement) of variants along a single chromosome is known as the haplotype, which is an important piece of the genetic puzzle of a disease. Haplotype cannot be determined from standard DNA sequencing, due to short read lengths.
Unlike conventional phasing methods that are tedious and expensive, Drop-Phase can be used to quickly and affordably determine the phase of multiple sequence variants in a region of interest after a sample has been sequenced. The resulting haplotype data can then be used to characterize how specific combinations of variants contribute to the severity of a disease.
Drop-Phase can also be used to screen individuals for specific haplotypes when sequencing data are unavailable. This is particularly valuable for prospective clinical trials.
"We expect researchers to use Drop-Phase to resolve the configuration of variants discovered from genome-wide association studies and determine whether certain haplotypes contribute to the severity of a disease," said John Regan, leader of the Advanced Droplet Digital PCR Applications Group at the Digital Biology Center and first author of the PLOS ONE paper. "For the first time, a technology is available that makes this work easy and affordable. This information will greatly accelerate our understanding of disease genomics, which is very exciting," he said.
"We hope Drop-Phase advances work in a variety of genetic fields, including clinical genetics, genome editing, and the analysis of allele-specific expression," said Steven McCarroll, professor of genetics at Harvard Medical School, director of genetics for the Stanley Center for Psychiatric Research at the Broad Institute, and the paper's senior author.
Drop-Phase Overcomes Challenges of Current Chromosomal Phasing Methods
Traditional methods for phasing pairs of variants involve long-range PCR, cloning, and/or manual dilution to single-molecule concentrations followed by sequencing and expensive library preparation methods that may require resequencing. Day-to-day use of these molecular phasing approaches is limited by cost, time requirements, and the distance between allelic markers. In contrast, Drop-Phase allows researchers to rapidly phase hundreds of samples at a low cost and at distances greater than 200 kb in a 96-well format. Additionally, using information across multiple reaction wells makes it possible to phase across vast regions of a chromosome.
Using ddPCR Technology To Determine If Allelic Makers Are on the Same Chromosome
The Drop-Phase method uses ddPCR technology to subdivide a DNA reaction mixture into thousands of nanoliter-sized droplets. "Our approach is based on a simple idea: when two allelic markers are physically linked they will partition into the same droplets," the article reports. Within each droplet, the DNA is amplified in the presence of two different fluorescent reporters specific to the allelic markers of interest. If a higher percentage of droplets is positive for both markers than expected by chance, the allelic markers are determined to be on the same chromosome.
Phasing Cystic Fibrosis Gene Variants Using Drop-Phase
For the PLOS ONE study, the authors used cystic fibrosis to illustrate the utility of Drop-Phase. Cystic fibrosis is a genetic disorder caused by variations within the 189-kb CFTR gene. Individuals with one compromised CFTR gene are carriers; individuals with both CFTR genes compromised have cystic fibrosis. Knowing the chromosomal phase of CFTR variants is important for predicting the severity of the disease. Using Drop-Phase, the researchers easily determined the chromosomal phase of CFTR variant pairs by revealing whether two mutations in a sample altered only one or both copies of the CFTR gene.
To conduct this study, the researchers used Bio-Rad's QX200™ Droplet Digital PCR System and its included QuantaSoft™ Software, which automatically calculates the number of linked copies per microliter for every duplex reaction performed. The paper also explains how QuantaSoft calculates the concentration of linked species and how to calculate the percentage of linked molecules in a sample.
Additional Applications for Drop-Phase
In addition to phasing variants, Drop-Phase can be used to validate the presence of somatic structural variants (for example, translocations) and map highly repetitive regions of the genome by estimating the genomic distance separating unique loci.
INFORMATION:
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) develops, manufactures, and markets a broad range of innovative products and solutions for the life science research and clinical diagnostic markets. The company is renowned for its commitment to quality and customer service among university and research institutions, hospitals, public health and commercial laboratories, as well as the biotechnology, pharmaceutical, and food safety industries. Founded in 1952, Bio-Rad is based in Hercules, California, and serves more than 100,000 research and healthcare industry customers through its global network of operations. The company employs more than 7,600 people worldwide and had revenues exceeding $2.1 billion in 2014. For more information, please visit http://www.bio-rad.com.
In a report of a proof-of-principle study of patients with colon and other cancers for whom standard therapies failed, researchers at the Johns Hopkins Kimmel Cancer Center say that mistakes in so-called mismatch repair genes, first identified by Johns Hopkins and other scientists two decades ago, may accurately predict who will respond to certain immunotherapy drugs known as PD-1 inhibitors. Such drugs aim to disarm systems developed by cancer cells to evade detection and destruction by immune system cells.
Results of the trial with pembrolizumab, marketed as Keytruda, ...
The recent floods in Texas have caused some of the worst flooding since Hurricane Ike in 2008, causing the rainiest month in the state's history.
What lessons have been learned from Ike's devastation of the Galveston and Houston area, and how have they helped in the prediction of future such storms?
Researchers at the Institute for Computational Engineering and Sciences at the University of Texas at Austin have been studying computational models and simulations of hurricanes like Ike in order to predict the consequences of such natural disasters and better prepare ...
PHOENIX -- If you are over age 75, and taking an anticoagulant, the old standard may be the gold standard, Mayo Clinic researchers and collaborators have determined.
In a study released online in April in the BMJ, a team of researchers from Mayo Clinic, and other collaborators, showed that for older patients, particularly individuals greater than 75 years of age, the risk of gastrointestinal (GI) bleeding is 3 to 5 times higher when taking newer anticoagulant medications dabigatran or rivaroxaban compared to when using warfarin.
One of the most common reasons people ...
At a traditional stone-laying ceremony outside La Serena, Chile on April 14th, construction officially began of the Large Synoptic Survey Telescope (LSST). This ambitious international astrophysics project is slated to start scanning the heavens in 2022. When it does, LSST should open up the "dark universe" of dark matter and dark energy--the unseen substance and force, respectively, composing 95 percent of the universe's mass and energy--as never before.
On April 2, 2015, the Director of LSST, Steven Kahn, along with astrophysicist Sarah Bridle and theoretical physicist ...
The study, published May 29 in the open access Nature Publishing Group journal Scientific Reports, reveals a direct link between the main culprit of Alzheimer's disease and memory loss.
Alzheimer's disease is characterized by the formation of amyloid plaques in the brain tissue. These amyloid plaques are made up of an insoluble protein, 'Amyloid-beta' (Abeta), which forms small structures called 'oligomers' that are important in the disease progression.
Although these proteins are known to be involved in Alzheimer's, little is understood about how they lead to memory ...
Stanford University scientists have created a new carbon material that significantly boosts the performance of energy-storage technologies. Their results are featured on the cover of the journal ACS Central Science.
"We have developed a 'designer carbon' that is both versatile and controllable," said Zhenan Bao, the senior author of the study and a professor of chemical engineering at Stanford. "Our study shows that this material has exceptional energy-storage capacity, enabling unprecedented performance in lithium-sulfur batteries and supercapacitors."
According to ...
One of the main health targets proposed by the UN Sustainable Development Goals (SDG) is to reduce by one-third premature mortality from non-communicable diseases such as cancer, stroke and dementia. The goals for 2016-2030 define premature mortality as deaths occurring among people aged 69 years old or younger.
The proposed SDG target sends an unambiguous statement to UN member states that health provision for younger groups must be prioritised at the expense of people aged 70 or more, according to the international group of signatories of the letter published in The ...
May 29, 2015 - Researchers are exploring new approaches to designing prosthetic hands capable of providing "sensory feedback." Advances toward developing prostheses with a sense of touch are presented in a special topic article in the June issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).
Emerging sensory feedback techniques will provide some sensation and enable more natural, intuitive use of hand prostheses, according to the review by ASPS Member Surgeon Paul S. Cederna, MD, of University ...
May 29, 2015 - As in adults, migraine surgery is effective for selected adolescent patients with severe migraine headaches that don't respond to standard treatments, reports a study in the June issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).
ASPS Member Surgeon Bahman Guyuron, MD, Emeritus professor of plastic surgery at Case School of Medicine, Cleveland, and colleagues report good outcomes in an initial experience with migraine surgery in younger patients. They write, "Our data demonstrate ...
May 29, 2015 - People with dementia and other forms of cognitive impairment (CI) have altered responses to pain, with many conditions associated with increased pain sensitivity, concludes a research review in PAIN®, the official publication of the International Association for the Study of Pain. The journal is published by Wolters Kluwer.
The available evidence questions the previous notion that people with CI have reduced pain sensitivity to pain. Rather, "It appears that those with widespread brain atrophy or neural degeneration...all show increased pain responses ...
